Biopharma Layoff Tracker 2024: BioMarin Pharmaceutical Inc., Repare, Genentech and more cut staff https://hubs.li/Q02N9TmJ0
BioSpace
Internet News
West Des Moines, Iowa 116,208 followers
The leading source for biopharma news and jobs. Connecting industry pioneers with talented professionals.
About us
BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe.
- Website
-
http://www.biospace.com/
External link for BioSpace
- Industry
- Internet News
- Company size
- 11-50 employees
- Headquarters
- West Des Moines, Iowa
- Type
- Privately Held
- Founded
- 1985
- Specialties
- biotech jobs, pharma jobs, biotech news, pharma news, and life sciences news
Locations
-
Primary
3001 Westown Pkwy
#101
West Des Moines, Iowa 50266, US
Employees at BioSpace
-
Greg Slabodkin
-
Dr. D. Martin Alexander Gershon, MD, JD, MPH
AI & Digital Health Innovation Keynote•Linkedin “Top Voice” Venture Capital, Entrepreneurship, & Fundraising•Techstars Sr EIR•Goldman…
-
Angela Gabriel
Content Manager (Life Sciences Careers) at BioSpace
-
Lori Ellis (Katz)
Head of Insights
Updates
-
NuCana’s chemotherapy replacement has failed to improve progression-free survival in a Phase II test, sending the biotech’s shares down by 50%. https://hubs.li/Q02N9-1N0 #pharma #biospace
NuCana Shares Plummet as Another Chemotherapy Replacement Fails Phase II
biospace.com
-
Despite the added survival benefit for its drug, Alnylam Pharmaceuticals still faces steep competition from Pfizer, whose ATTR-CM therapies have become established treatment options. https://hubs.li/Q02N9-sP0 #pharma #biospace
Alnylam Builds ATTR-CM Case for Vutrisiran With Strong Phase III Survival Data
biospace.com
-
Eli Lilly and Company this week announced plans to sell single-dose vials of its weight loss drug Zepbound directly to consumers. Novo Nordisk could adopt a similar strategy for Wegovy as its CEO is set to testify Sept. 24 before the Senate health committee. https://hubs.li/Q02N9Lfy0
With Lilly’s Zepbound Price Cut and Novo’s Impending Senate Hearing, Wegovy Is in the Hot Seat
biospace.com
-
J&J gained rights to the FcRn blocker nipocalimab when it acquired Momenta Pharmaceuticals in August 2020 for $6.5 billion. https://hubs.li/Q02N9Hdg0 #pharma #biospace
J&J Poised to Challenge Argenx With Myasthenia Gravis Filing for Nipocalimab
biospace.com
-
In agreeing with Novo Nordisk and Eli Lilly and Company, Pennsylvania judge Karen Spencer Marston said the court should first settle questions of gastroparesis diagnosis and sufficient warnings for side effects. https://hubs.li/Q02N9BFb0 #pharma #biospace
Siding With Novo and Lilly, Court Agrees to First Tackle ‘Cross Cutting Issues” in GLP-1 Litigations
biospace.com
-
Emergent BioSolutions joins Bavarian Nordic on pharma’s frontline in the fight against the ongoing mpox emergency. https://hubs.li/Q02N9vmV0 #pharma #biospace
Emergent Wins FDA Approval for Mpox Vaccine as Outbreak Rages On
-
Last week, BioMarin Pharmaceutical Inc. revealed changes to its C-suite; now, the company has announced its second round of layoffs this year, following the termination of 170 employees in May. https://hubs.li/Q02N55Mr0 #pharma #biospace
BioMarin to Lay Off 225 Employees Globally
biospace.com
-
In Texas, the Plano City Council approved a development agreement that supports a planned project that would bring over 3 million square feet of life sciences space to the area. https://hubs.li/Q02N54lv0 #pharma #biospace
Texas Life Sciences Redevelopment Project Moves Closer to Reality
biospace.com
-
Merck continued its clinical losing streak on Thursday with the announcement that it is discontinuing late-stage studies of the anti-PD-1 therapy in non-small cell lung cancer and cutaneous squamous cell carcinoma. https://hubs.li/Q02N2PkT0 #pharma #biospace
Merck Axes Two Keytruda Phase III Cancer Trials Due to Disappointing Data
biospace.com